RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. - Wikidata - awgldk - TriplyDB

RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.

RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.

http://www.wikidata.org/entity/Q35662070

about

Neuroinflammation and psychiatric illness Circadian Mechanisms Underlying Reward-Related Neurophysiology and Synaptic Plasticity Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling Investigating the mechanism(s) underlying switching between states in bipolar disorder Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.Modeling mania in preclinical settings: A comprehensive review.Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features.The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.Neuropathological responses to chronic NMDA in rats are worsened by dietary n-3 PUFA deprivation but are not ameliorated by fish oil supplementation.The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment Reduced dopamine transporter expression in the amygdala of subjects diagnosed with schizophrenia.Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous system Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder The importance of the excitatory amino acid transporter 3 (EAAT3)Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder Klotho sensitivity of the neuronal excitatory amino acid transporters EAAT3 and EAAT4.The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.Disturbance of the glutamatergic system in mood disorders.Association of rare variation in the glutamate receptor gene SLC1A2 with susceptibility to bipolar disorder and schizophrenia.The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.Vulnerability of synapses in the frontal cortex of mice developmentally exposed to an insecticide: Potential contribution to neuropsychiatric disease.Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.Serotonergic dysfunction in patients with bipolar disorder assessed by the loudness dependence of the auditory evoked potential.Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability.Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia Label-Free Proteomic Analysis of Protein Changes in the Striatum during Chronic Ethanol Use and Early Withdrawal Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients.Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean Cohorts Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder.Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.Neuropathology of mood disorders: do we see the stigmata of inflammation?Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders.Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins.The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder.The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment.

P2860

Q21245244-0E961950-D690-4ED8-99D1-34BFBB124BE4 Q26770416-AB7318D1-FFC0-4B2A-A543-5D6E29FDA968 Q26850084-B8091A55-E7D5-4393-9A03-BEB2AC5ABBE4 Q26864995-8170F0DE-9DCD-4D52-B6E6-7676F0FE50BF Q28084519-881401AA-BE66-40FD-9B97-60F0269B90C4 Q28085253-118672E3-7BCA-4BF2-870C-3BEDEF73E436 Q30359575-AF42350F-D267-47E8-A60F-C1F9511CC8EF Q30375478-6808B538-7A38-469B-B381-65313EAEB856 Q30437188-81856A0E-3703-4D92-BC5E-C719DBB59377 Q33567704-7DDB8F8A-AA20-4892-863D-D0C2E71CBBBE Q33593061-613885AF-F3F5-4591-88CA-DB1E3CA612F0 Q34048658-51B5E5E8-21F8-4355-8F1D-E87509765395 Q34099708-878243D0-A059-49A6-A9DF-5DD68AC0BFC2 Q34406087-DD3B5A3D-C124-40EA-9354-34DF69CC9490 Q34499376-631D39BD-E6D9-4FDA-A0EE-E77D2583A792 Q34528594-F1CB8961-B4D7-4E7D-AA60-010DA8BD7CA1 Q34588846-BB7201D7-C1BB-4D4E-89A2-175852156237 Q34907600-2B1C7FD6-C666-4A74-B73A-84CB5A16B9A3 Q35054681-D409C252-1973-42B4-8692-C74F7BE77A0C Q35149888-269D3318-5327-469E-A93C-BDFA1637280A Q35154322-5F5AD796-881F-4E15-9E8C-86A1F8FC7BC6 Q35186635-A69F00C2-0570-40AE-8560-F77DF30C1AF5 Q35680065-88002C36-A817-46FF-8B5B-7784EFA831E1 Q35742545-844B4050-557B-45CA-9ECD-E3B80C3F9EE0 Q36229952-91D6F4EA-2A02-49A0-8C28-BDE24B42AFFA Q36338174-8C54A42D-8102-4585-A41E-84AB717E2FB3 Q36518167-3A000E24-A212-4D02-91C6-6108B4D5726A Q36609289-B2085994-B724-4EB5-B1FC-AF6C4791DE27 Q36674162-D6D3467C-BC5C-4332-9C96-CCB0D4C5257F Q36750552-6B03EAE6-1F62-42B3-8BC4-738D53FF2B00 Q36817270-8F61A04C-5C2E-4D2F-83D6-345F7872575E Q36955877-2F246DCB-BB34-42ED-8585-1E1D275EA89A Q37267763-8DD1CD85-F565-4681-861B-DD8A7D634C78 Q37585078-DDC6A6C9-99F6-4E8C-BE83-94BDB81B945E Q37629424-1B98CB7A-E349-4C93-8848-81C71E59D9BB Q37648274-94F46679-27C5-4EB3-93A1-B0E9665E73AD Q38019745-64F9A5B3-277C-4468-829B-8AE3F8FAE91F Q38024032-AD9D45F3-8B7F-4EDE-8624-A50122E0AEA8 Q38031289-7F473CE3-8F6E-459A-B0D7-231A78AB4581 Q38189780-794D4B95-E0ED-476F-925E-F22F625707A1

P2860

RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.

http://www.wikidata.org/entity/Q35662070

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

RETRACTED: Dysregulated glutam ...... ar and schizophrenic patients.

@ast

RETRACTED: Dysregulated glutam ...... ar and schizophrenic patients.

@en

type

label

RETRACTED: Dysregulated glutam ...... ar and schizophrenic patients.

@ast

RETRACTED: Dysregulated glutam ...... ar and schizophrenic patients.

@en

prefLabel

RETRACTED: Dysregulated glutam ...... ar and schizophrenic patients.

@ast

RETRACTED: Dysregulated glutam ...... ar and schizophrenic patients.

@en

P1433

Q35662070-6E37E512-C74F-4C29-8AF1-AE293410846A

P1476

Q35662070-93E3B471-E791-4020-80E6-8C2C36BECFA5

P2093

Q35662070-51FCEF9E-9E13-4398-AEA3-A84738301C4A

Q35662070-C7FAE099-BB9B-4AB3-B73D-E5851D77AC2C

Q35662070-DAD58D2E-A5B8-4381-BC15-52BD96983523

Q35662070-EF354592-0757-4056-9634-430531FEEC70

Q35662070-EFC00760-EFF0-42CC-B249-59707D5FE5B2

P2860

Q35662070-0035A515-1B41-4DE8-89A0-0EDEAED24FF0

Q35662070-008FC774-48F8-4515-844D-7278E6CFB364

Q35662070-04F03E92-7D4A-487B-A0FE-22F97495123D

Q35662070-0720EDE5-64D5-4A26-822B-14C3CDD07BA7

Q35662070-0981C771-523C-40CF-85F3-6BD1F089EA4B

Q35662070-15DEA3A5-565D-4EF6-A6B0-BAD1740459C4

Q35662070-1647CBF1-7617-40AF-80BF-E08CB0865D83

Q35662070-1E4309C2-249A-4C5E-9DDA-7A3FEF1CDEBA

Q35662070-21F2D73F-321F-4574-898A-9DD78B23DDC3

Q35662070-23E7E4D6-E36A-45B9-B322-8B1051D357B2

P304

Q35662070-257CEEAD-8AD1-457F-94AB-ABE9B9A2069D

P31

Q35662070-D441CCEA-2213-4EBD-A636-6C19FC7D4143

P356

Q35662070-CDBEAF47-88AA-45E2-AF5A-29C794E3167A

P433

Q35662070-8197E88A-58D0-4259-9309-41BA701B03AC

P478

Q35662070-B0669D24-67B0-4C71-960B-0A092366E2D8

P577

Q35662070-55D3AEBC-C27F-42B0-A37A-77DB17E497E8

P5875

Q35662070-C1D311CB-4985-4DE8-816E-96558AC1EAAB

P698

Q35662070-DC80C90B-C898-4272-A569-947E5B56ED35

P921

Q35662070-3E7AD179-A31F-4606-A338-F06B8EF017F6

P932

Q35662070-AAC78B78-4E8B-4515-A04A-C844A60E3B8F

P356

J.JAD.2011.08.017

P1433

Journal of Affective Disorders

P1476

RETRACTED: Dysregulated glutam ...... ar and schizophrenic patients.

@en

P2093

Edmund Arthur Reese

http://www.w3.org/2001/XMLSchema#string

Hyung-Wook Kim

http://www.w3.org/2001/XMLSchema#string

Jagadeesh Sridhara Rao

http://www.w3.org/2001/XMLSchema#string

Matthew Kellom

http://www.w3.org/2001/XMLSchema#string

Stanley Isaac Rapoport

http://www.w3.org/2001/XMLSchema#string

P2860

Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia

Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance

Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease

Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain

The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse?

Distribution of glutamate transporter subtypes during human brain development

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1

P304

63-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAD.2011.08.017

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51650166

http://www.w3.org/2001/XMLSchema#string

P698

21925739

http://www.w3.org/2001/XMLSchema#string

P921

P932

3254216

http://www.w3.org/2001/XMLSchema#string